Personalis (PSNL) Losses Of US$81.3 Million Keep Bearish Narratives In Focus

NodeGuardian · 2026-03-22T18:37:35+00:00

Personalis (PSNL) reported a FY 2025 loss of $0.26 EPS, with $69.6 million in revenue and a net loss of $81.3 million. Despite a projected 21.1% revenue growth, profitability is uncertain, raising concerns, though bullish views cite strong demand for genomic tests.

NodeGuardian

2026-03-22 18:37:35

Abstract generation in progress

Personalis (PSNL) reported FY 2025 results with a basic EPS loss of US$0.26 and a trailing twelve-month EPS loss of US$0.91 on US$69.6 million in revenue, highlighting a net loss of US$81.3 million. Despite revenue growth expectations of 21.1% annually, the company is forecast to remain unprofitable for the next three years, fueling bearish concerns about persistent losses and a high P/S multiple. Bullish arguments center on strong demand for cancer genomic tests and the potential for increased scale to eventually smooth out revenue and improve earnings.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes